Recent Updates
Recently added Catalysts
AKBA Positive Sentiment

Akebia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference

Thursday, May 28, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Akebia Therapeutics will present at the 2026 Jefferies Global Healthcare Conference on June 4, 2026. Key executives Erik Ostrowski and Nicholas Grund will represent the company. A live webcast of the presentation will be available, along with a replay for 90 days. The conference runs from June 2-4, 2026, in New York.
Price reaction · baseline $1.03 (2026-05-27 close) · hit after-hours · 1 other AKBA headline(s) in the window, move may be shared
day 0 close · peak
+1.9%

Conference Participation Details

Jefferies Global Healthcare Conference
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Market Sentiment Analysis

POSITIVE FACTORS

  • Akebia Therapeutics is actively participating in a major healthcare conference.
  • The presentation will feature key executives, highlighting the company's leadership.
  • The live webcast allows for broader access to their insights.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+1%
120-day peak, hindsight
Typical move
8%
average across 4 past catalysts
Lead asset
ferric
Phase 3 · Anemia of Chronic Kidney Disease

Full Press Release Details

CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) --Akebia Therapeutics®, Inc.(Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that Erik Ostrowski, Chief Financial and Business Officer, and Nicholas Grund, Chief Commercial Officer, will present at the 2026 Jefferies Global Healthcare Conference on Thursday, June 4, 2026 at 7:35 AM ET in New York, NY.
A live webcast of the presentation can be accessed through the “Investors” section of Akebia’s website athttps://ir.akebia.com. A replay of the webcast will also be available for 90 days following the presentation.
The 2026 Jefferies Global Healthcare Conference will take place June 2-4, 2026, in New York, NY.
About Akebia TherapeuticsAkebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website atwww.akebia.com, which does not form a part of this release.

Akebia Therapeutics ContactMercedes Carrascomcarrasco@akebia.com

Frequently Asked Questions

When will Akebia present at the Jefferies Conference?

Akebia will present on June 4, 2026, at 7:35 AM ET.

Who will represent Akebia at the conference?

Erik Ostrowski and Nicholas Grund will represent Akebia.

How can I access the presentation?

The presentation will be available via a live webcast on Akebia's website.

What are the dates of the Jefferies Global Healthcare Conference?

The conference takes place from June 2-4, 2026.

ShareAdd on Google
Tags: AKBA Viatris Investor Conferences Healthcare Akebia Therapeutics Jefferies Conference kidney disease healthcare presentation
Last updated: May 28, 2026

Conference Timeline

Nov 11, 2025
UBS Global Healthcare Conference
8:45 AM ET • Fireside Chat
Nov 18, 2025
Jefferies Global Healthcare
11:30 AM GMT • London

Biotech snapshot

Cash runway
$156M liquidity · $0M/mo burn
Low dilution risk
Lead asset
ferricPhase 3
Anemia of Chronic Kidney Disease →

Catalyst track record

+1%
best trade around AKBA's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for AKBA.

See every catalyst's timing & PoA →